The document is a company's COVID-19 policy outlining guidelines and procedures for employees during the pandemic. It details how COVID-19 spreads, symptoms, and requirements for employees who are sick or exposed. The policy mandates hygiene practices like handwashing and disinfecting surfaces. It restricts travel and large meetings, requires masks, and appoints COVID managers to implement safety plans and monitor compliance. Employees who violate the policy will face disciplinary action.
With the Coronavirus outbreak on this scale, we can caution ourselves with this bio-security package from Chemtex Speciality Limited. It limits the spread of the pandemic by ramping up the hygiene norms.
With the Coronavirus outbreak on this scale, we can caution ourselves with this bio-security package from Chemtex Speciality Limited. It limits the spread of the pandemic by ramping up the hygiene norms.
This guideline is part of the COVID-19 Management Guidelines in Malaysia No.5 / 2020 (Last Update on 26 February 2021). For other guidelines, please go to http://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm
Thulas Nxesi briefing on COVID-19 Level 4 regulationsSABC News
The Minister of Employment and Labour Thulas Nxesi says that his department is working with the Department of Health to ensure that employers prioritise lockdown regulations and the health of workers.
Plan Sponsor Webinar: Navigating COVID-19 for Employersbenefitexpress
In this webinar, we take a deeper look into how the novel coronavirus is not only affecting the way we live, but changing the way we work. From remote work environments, FMLA, contract agreements and more, we discuss how to navigate the changing workforce during this time of uncertainty, and answer questions to help you make the best decisions for the health and safety of your employees.
This guideline is part of the COVID-19 Management Guidelines in Malaysia No.5 / 2020 (Last Update on 26 February 2021). For other guidelines, please go to http://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm
Thulas Nxesi briefing on COVID-19 Level 4 regulationsSABC News
The Minister of Employment and Labour Thulas Nxesi says that his department is working with the Department of Health to ensure that employers prioritise lockdown regulations and the health of workers.
Plan Sponsor Webinar: Navigating COVID-19 for Employersbenefitexpress
In this webinar, we take a deeper look into how the novel coronavirus is not only affecting the way we live, but changing the way we work. From remote work environments, FMLA, contract agreements and more, we discuss how to navigate the changing workforce during this time of uncertainty, and answer questions to help you make the best decisions for the health and safety of your employees.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
1. [COMPANY LOGO]
DOC NO 01
REV DATE 2021/04/30
ISSUED 2020/05/01
PAGES 5
SECTION RISK MANAGEMENT
SUB-SEC HSE GUIDELINES
SUBJECT COVID-19 POLICY
1. OBJECTIVE
1.1 The aim of this policy is to ensure a safe working environment for all employees and to stop the
spreadof the Coronavirus Disease 2019 “COVID-19” virus. Section 8 of the Occupational Health
and Safety Act, 1993 “OHSA” requires every employer to provide and maintain, as far as
reasonably practicable, a working environment that is safe and without risks to the health of its
employees. Similarly, the OHSA also imposes a duty on employees to take reasonable care of
their own health and safety and that of their fellow employees.
1.2 Information pertaining to COVID-19 is being provided by various authorities on a regular basis
and it is important to ensure that updates are obtained and disseminated through the organisation.
Please refrain from forwarding information related to the virus without having checked it with
credible sources such as the World Health Organisation “WHO” and the National Institute for
Communicable Diseases “NICD”. Spreading unverified information may contribute to
unnecessary panic, stigma and discrimination, all of which do not add value at this stage.
1.3 This policy is susceptible to changes with the introduction of additional governmental guidelines
and accordingly will be updated if, and when, required.
2. APPLICATION
This policy includes measures being taken to mitigate the spread of COVID-19. You are kindly
requested to follow all these requirements to sustain a healthy and safe workplace. It is important
that we all respond responsibly and transparently to these health precautions.
3. CONTENT
3.1 How does COVID-19 spread?
COVID-19 is most likely to spread when there is close contact (1.5 metres or less) with an
infected person. It is likely that the risk increases as the period of exposure to an infected person
lengthens. Contaminated droplets produced when an infected person coughs or sneezes are the
main means of transmission. There are two main routes by which people can spread COVID-19:
Infection can be spread to people who are nearby as droplets are inhaled into the lungs.
It is also possible that someone may become infected by touching a surface,object or the hand
of an infected person who has been contaminated and then touching their own mouth, nose, or
eyes.
2. 3.2 Primary symptoms of COVID-19
The following symptoms may develop up to 21 days after exposure to someone who has
COVID-19:
Cough
Sore throat
Fever
Shortness of breath/ difficulty in breathing
Redness of eyes
Body aches
Loss of smell
Loss of taste
Nausea
Vomiting
Diarrhoea
Fatigue
Weakness
Infections can cause more severe symptoms in people who are over the age of 60 and those with
compromised immune systems such as diabetes, cancer and chronic lung disease.
3.3 What to do if you develop symptoms
People who contract COVID-19 may take anywhere from one to twenty-one days to develop
symptoms. Even if you do not have a history of travel to a COVID-19 affected region or contact
with an individual who has contracted the illness, you must still inform your healthcare provider
if you present with symptoms of COVID-19.
Hotline for the COVID-19 as per the Department of Health website:
Employees should notify their line manager / supervisor and stay at home if they are sick and
have been booked off. All employees should follow the company’s sick leave policy in such
situations. If the company has reasonto suspectthat an employee has been infected with COVID-
19 or an employee becomes ill at work, the employer will request the employee to leave the
workplace and seek medical treatment and/or testing immediately.
3. 3.4 Quarantine and working from home
If an employee has been in close contact with an individual who has since been diagnosed with
COVID-19, the employee must immediately inform their employer and contact the COVID-19
Hotline. Close contactmeansthat the employee wasin face-to-face contact(i.e.within 1.5 metres)
or in a closed space for more than 15 minutes with a person with COVID-19.
If, after informing the Department of Health, the employee is required to self-quarantine then the
following policies will apply:
If the employee is able to work during this period, then there is no requirement to submit a
sick leave or annual leave request. The employee is, however, required to report daily to their
line manager.
Should the employee become sick during this period, then normal sick leave policy will
apply, if the employee’s sick leave entitlement under the section is exhausted, management
make application for an illness benefit in terms of clause 4 of the Directive issued on 25
March 2020 on the COVID-19 Temporary Employer Relief Scheme under regulation 10(8)
of the Regulations promulgated in terms of section 27(2) of the Disaster Management Act;
3.5 Travel
All domestic flight travel is suspended until further notice unless absolutely necessary as
determined by the parties concerned. Local travel to clients will still be required but must be done
in line with current protocols of low contact and high hygiene. In this instance, the company will
also be guided by their clients in terms of the clients' needs and expectations. All non-essential
travel, particularly on public transport, is discouraged.
3.6 Meetings
Consider whether a face-to-face meeting or event is needed - could it be replaced by a
teleconference or any other electronic platform.
Could the meeting be scaled down so that fewer people attend?
Ensure that all participants in the meeting have washed their hands for 20 seconds or utilised
a hand sanitiser prior to the meeting commencing.
Ensure that all delegates are seated at least one and a half metre apart.
The names and contact details of all participants in the meeting should be retained for at least
one month. This may be done through the completion of a register and will assist healthcare
authorities in tracing those who have been exposed to COVID-19 if a participant does become
ill with the virus shortly after the meeting.
If a participant should contract the virus shortly after the meeting, the company must inform
all participants.
3.7 Hygiene in the workplace
All visitors and employees entering the offices must be requested by the receptionist to wash
their hands or utilise a hand sanitiser on entering the premises.
4. Coughs and sneezes must be covered with a tissue; the tissue must be disposed of in the
relevant waste bin.
Frequently touched objects, including workstations and surfaces, must be cleaned and
disinfected using a regular household cleaning spray or wipe.
Wash your hands often with soap and water for at least 20 seconds, especially after going to
the bathroom, before eating and after blowing your nose, coughing, or sneezing.
If soap and water are not readily available, an alcohol-based hand sanitiser with at least 70%
alcohol must be used.
Handshakes with any staff or clients must be AVOIDED; one’s face should not be touched
either.
3.8 Wearing face masks
The use of face masks covering the mouth and nose is compulsory, when in public, entering any
building, premises, work and when utilising public transport. Persons without a face mask will
not be permitted to enter the worksite, as required by Chapter 5(1) and 5(2) of the Risk
Adjustment Strategy Regulations (29 April 2020).
3.9 Seminars, Training and Conferences
No employee may attend external seminars, training or conferences, unless approved by the
Managing Director. The presentation of seminars and training to clients will be converted to
online/blended facilitation.
3.10 COVID-19 Manager
A COVID-19 Manager will be appointed to ensure the implementation of and adherence to
Standard Operating Procedures for the risk mitigation of COVID-19 in the workplace, as
required by Government Notice NO. 479 29 APRIL 2020 - 479 Disaster Management Act
(57/2002): Covid-19 Occupational Health and Safety Measures in Workplaces Covid-19 (C19
OHS), 2020 and the Risk Adjustment Strategy Regulations of 29 April 2020. It is recommended
that a COVID-19 Response Team is also appointed to assist, where necessary, with the
implementation of and adherence to Standard Operating Procedures for the risk mitigation of
COVID-19 in the workplace.
3.11 COVID-19 Compliance Officer
A COVID-19 Compliance Officer will be appointed, which may be the same appointee
as the COVID-19 Manager. The Compliance Officer is required to develop a plan for the
phased in return of employees to the workplace, prior to reopening the workplace for
business. The plan must include the following:
Which employees are permitted to work;
What the plans for the phased-in return of their employees to the workplace are;
What health protocols are in place to protect employees from COVID-19; and
The details of the COVID-19 Compliance Officer;
5. 3.12 Consequence of breach
If an employee breaches this policy the necessary disciplinary action will be taken. It is important
to note that the company’s sick leave policy will not be adjusted or become flexible during the
outbreak of COVID-19. The normal sick leave policy which is in line with Labour Law will still
apply.
It is the employee’s responsibility to contact management should he/she have any queries related to this
Policy.
CEO Signature
Date